Clinical Trial Update: Dabigatran Following Transient Ischemic Attack and Minor Stroke [Phase 2]

View source ↗

Summary

A Phase 2 trial of dabigatran for patients after transient ischemic attack or minor stroke has completed. The update does not include the trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Minor Ischemic Stroke
• Transient Ischemic Attack

Drugs mentioned

• Dabigatran (Dabigatran etexilate)

Snippet

Sponsor: University of Alberta | Conditions: Transient Ischemic Attack, Minor Ischemic Stroke | Phase 2 | Status: COMPLETED